Skip to main content

Table 2 Predicted and observed number of events according to PSI and CURB65 risk category in CAP patients (n = 925)

From: Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections

PSI class

1

2

3

4

5

Predicted death risk (%)*

0.18%

0.63%

2.74%

8.31%

29.62%

Observed data

     

- n

104

139

180

351

151

- Number of deaths

0 (0.0%)

0 (0.0%)

1 (0.6%)

23 (6.6%)

26 (17.2%)

- Number of ICU or death

4 (3.8%)

7 (5.0%)

8 (4.4%)

55 (15.7%)

44 (29.1%)

- Number of serious complications

5(4.8%)

12 (8.6%)

13 (7.2%)

60 (17.1%)

44 (29.1%)

CURB65 score

0

1

2

3

4 or 5

Predicted death risk (%)*

0.58%

1.66%

9.02%

16.11%

35.10%

Observed data

     

- n

194

233

296

167

35

- Number of deaths

0 (0.0%)

4 (1.7%)

25 (8.4%)

10 (6.0%)

11 (31.4%)

- Number of ICU or death

6 (3.1%)

19 (8.2%)

44 (14.9%)

31 (18.6%)

18 (51.4%)

- Number of serious complications

7 (3.6%)

30 (12.9%)

46(15.6%)

33(19.8%)

18(51.4%)

  1. * Based on risks reported in the original PSI and CURB65 publications (derivation and validation cohorts) [4, 6].